Effect of human milk prostaglandins and lactoferrin on respiratory syncytial virus and rotavirus

Acta Paediatrica, International Journal of Paediatrics

Volumn 86, Issue 3, 1997, Pages 315-316

  Grover, M ^a   Giouzeppos, O ^a   Schnagl, R D ^a   May, J T ^a  

^a LA TROBE UNIVERSITY   (Australia)

Author keywords

human milk; lactoferrin; prostaglandins; viruses

Indexed keywords

LACTOFERRIN; PROSTAGLANDIN;

ARTICLE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; ROTAVIRUS; VIROGENESIS;

EID: 0030946764     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.1997.tb08896.x     Document Type: Article

References (14)

1. Welsh JK, May JT. Anti-infective properties of breast milk. J Pediatr 1979; 94: 1-9
2. May JT. Antimicrobial factors and microbial contaminants in human milk: Recent studies. J Pediatr Child Health 1994; 30: 470-5
3. Brüssow H, Benitez O, Uribe F, Sidoti J, Rosa K, Cravioto A. Rotavirus-inhibitory activity in serial milk samples from Mexican women and rotavirus infections in their children during the first year of their life. J Clin Microb 1993; 31: 593-7
4. Lægreid A, Kolstø Otnæss AB, Ørstavik I, Carlsen KH. Neutralizing activity in human milk fractions against respiratory syncytial virus. Acta Pædiatr Scand 1986; 75: 696-701
5. Giugliano LG, Ribeiro STG, Vainstein MH, Ulhoa CJ. Free secretory component and lactoferrin of human milk inhibit the adhesion of enterotoxigenic Escherichia coli. J Med Microbiol 1995; 42: 3-9
6. Harmsen MC, Swart PJ, de Bèthune MP, Pauwels R, DeClercq E, The TH, et al. Antiviral effects of plasma and milk proteins: lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro. J Infect Dis 1995; 172: 380-8
7. Fujihara T, Hayashi K. Lactoferrin inhibits herpes simplex virus type 1 (HSV-1) infection of mouse cornea. Arch Virol 1995; 140: 469-72
8. Hughes-Fulford M, McGrath MS, Hanks D, Erickson S, Pulliam L. Effect of dimethyl prostaglandin A, on herpes simplex virus and human immunodefficiency virus replication. Antimicrob Agents Chemother 1992; 36: 2253-8
9. Neu J, Wu-Yang CY, Measel CP, Gimotty P. Prostaglandin concentrations in human milk. Am J Clin Nutr 1988; 47: 649-52
10. Luczak M, Gumulka W, Szmigielski S, Korbecki M. Inhibition of multiplication of parainfluenza 3 virus in prostaglandin-treated WISH cells. Arch Virol 1995; 49: 377-80
11. Cattral MS, Altraif I, Greig PD, Blendis L, Levy GA. Toxic effects of intravenous and oral prostaglandin E therapy in patients with liver disease. Am J Med 1994; 97: 369-73
12. Emau P, Giri SN, Bruss ML. Viral-bacterial pneumonia in calves: effect of plasma eicosanoids and long chain fatty acids. Int J Tiss Rec 1987; IX: 199-214
13. Girshwin LJ, Giri SN, Stewart RS, Chen J. Prostaglandin and thromboxane concentrations in plasma and lung lavage fluids during sequential infection of vaccinated and nonvaccinated calves with bovine respiratory syncytial virus. Am J Vet Res 1989; 50: 1254-62
14. Welsh JK, Skurrie IJ, May JT. Use of Semliki Forest virus to identify lipid-mediated antiviral activity and antialphavirus immunoglobulin A in human milk. Infect Immun 1978; 19: 395-401